408 related articles for article (PubMed ID: 17010038)
21. Control of rabbit viral haemorrhagic disease in Benin by vaccination.
Kpodekon M; Alogninouwa T
Vet Rec; 1998 Dec 19-26; 143(25):693-4. PubMed ID: 9921627
[No Abstract] [Full Text] [Related]
22. A serological survey of antibodies to rabbit haemorrhagic disease virus (rabbit calicivirus disease) in two rural Central Otago communities.
Greenslade E; Weinstein P; Woodward A; Capucci L; Salmond C; Beasley R
N Z Med J; 2001 Feb; 114(1126):55-7. PubMed ID: 11280425
[TBL] [Abstract][Full Text] [Related]
23. Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit.
Yang L; Hu Y; Xue J; Wang F; Wang D; Kong X; Li P; Xu W
Vaccine; 2008 Aug; 26(35):4451-5. PubMed ID: 18602959
[TBL] [Abstract][Full Text] [Related]
24. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
[TBL] [Abstract][Full Text] [Related]
25. Development of an RT-PCR for rabbit hemorrhagic disease virus (RHDV) and the epidemiology of RHDV in three eastern provinces of China.
Yang L; Wang F; Hu B; Xue J; Hu Y; Zhou B; Wang D; Xu W
J Virol Methods; 2008 Jul; 151(1):24-9. PubMed ID: 18499276
[TBL] [Abstract][Full Text] [Related]
26. Evolution of rabbit haemorrhagic disease virus (RHDV) in the European rabbit (Oryctolagus cuniculus) from the Iberian Peninsula.
Muller A; Freitas J; Silva E; Le Gall-Reculé G; Zwingelstein F; Abrantes J; Esteves PJ; Alves PC; van der Loo W; Kolodziejek J; Nowotny N; Thompson G
Vet Microbiol; 2009 Mar; 135(3-4):368-73. PubMed ID: 18977620
[TBL] [Abstract][Full Text] [Related]
27. Construction and immunogenicity of novel bivalent virus-like particles bearing VP60 genes of classic RHDV(GI.1) and RHDV2(GI.2).
Qi R; Miao Q; Zhu J; Tang J; Tang A; Wang X; Dong D; Guo H; Liu G
Vet Microbiol; 2020 Jan; 240():108529. PubMed ID: 31902498
[TBL] [Abstract][Full Text] [Related]
28. Recombination in rabbit haemorrhagic disease virus: possible impact on evolution and epidemiology.
Forrester NL; Moss SR; Turner SL; Schirrmeier H; Gould EA
Virology; 2008 Jul; 376(2):390-6. PubMed ID: 18455748
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis of peripheral blood leukocytes from rabbits infected with non-haemagglutinating strains of rabbit haemorrhagic disease virus (RHDV).
Niedźwiedzka-Rystwej P; Deptuła W
Vet Immunol Immunopathol; 2012 Sep; 149(1-2):54-7. PubMed ID: 22749701
[TBL] [Abstract][Full Text] [Related]
30. Adverse reactions in wild, free-ranging European rabbits vaccinated against rabbit haemorrhagic virus.
Twigg LE; Wheeler AG; Parkinson J
Aust Vet J; 1997 Jun; 75(6):448-9. PubMed ID: 9247699
[No Abstract] [Full Text] [Related]
31. Assessment of antibodies to rabbit haemorrhagic disease virus in fox serum as an indicator of infection in sympatric rabbit populations.
Philbey AW; Kirkland PD; Saunders GR
Aust Vet J; 2005; 83(1-2):97-100. PubMed ID: 15971829
[TBL] [Abstract][Full Text] [Related]
32. Effect of colibacillosis on the immune response to a rabbit viral haemorrhagic disease vaccine.
Eladl AH; Farag VM; El-Shafei RA; Elkenany RM; Elsayed MM; Mona MM; Ali HS; Saif MA
Vet Microbiol; 2019 Nov; 238():108429. PubMed ID: 31648721
[TBL] [Abstract][Full Text] [Related]
33. Monitoring the spread of rabbit hemorrhagic disease virus as a new biological agent for control of wild European rabbits in Australia.
Kovaliski J
J Wildl Dis; 1998 Jul; 34(3):421-8. PubMed ID: 9706550
[TBL] [Abstract][Full Text] [Related]
34. Dynamic alterations in selected indices of non-specific cell-mediated immunity in rabbits experimentally infected with VHD (viral hemorrhagic disease) virus.
Tokarz-Deptuła B; Hukowska B; Deptuła W
Pol J Vet Sci; 2003; 6(3 Suppl):70-3. PubMed ID: 14509370
[TBL] [Abstract][Full Text] [Related]
35. A competition ELISA for the detection of antibodies to rabbit haemorrhagic disease virus.
Collins BJ; White JR; Lenghaus C; Boyd V; Westbury HA
Vet Microbiol; 1995 Jan; 43(1):85-96. PubMed ID: 7716886
[TBL] [Abstract][Full Text] [Related]
36. Rabbit haemorrhagic disease: advantages of cELISA in assessing immunity in wild rabbits (Oryctolagus cuniculus).
Zheng T; Parkes JP
Vet Microbiol; 2011 Dec; 153(3-4):387-92. PubMed ID: 21719216
[TBL] [Abstract][Full Text] [Related]
37. The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus.
Strive T; Wright J; Kovaliski J; Botti G; Capucci L
Virology; 2010 Mar; 398(1):125-34. PubMed ID: 20034646
[TBL] [Abstract][Full Text] [Related]
38. Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia.
Cooke BD; Robinson AJ; Merchant JC; Nardin A; Capucci L
Epidemiol Infect; 2000 Jun; 124(3):563-76. PubMed ID: 10982081
[TBL] [Abstract][Full Text] [Related]
39. Detection of rabbit haemorrhagic disease virus (RHDV) in nonspecific vertebrate hosts sympatric to the European wild rabbit (Oryctolagus cuniculus).
Merchán T; Rocha G; Alda F; Silva E; Thompson G; de Trucios SH; Pagés A
Infect Genet Evol; 2011 Aug; 11(6):1469-74. PubMed ID: 21600308
[TBL] [Abstract][Full Text] [Related]
40. Confirmation and phylogenetic analysis of rabbit hemorrhagic disease virus in free-living rabbits from the Netherlands.
van de Bildt MW; van Bolhuis GH; van Zijderveld F; van Riel D; Drees JM; Osterhaus AD; Kuiken T
J Wildl Dis; 2006 Oct; 42(4):808-12. PubMed ID: 17255447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
